Table 2.
Comparison of ΔMAS,ΔFMA and ΔMBI scores between the two groups (duration of the disease 1–3 months)
| Outcomes | CR | TN | Between 2 Groups | |
|---|---|---|---|---|
| z | P‐value | |||
| ΔMAS‐Elbow flexors muscle | ||||
| Baseline‐WK2 | 0.10 ± 0.36 (0.04, 0.17) | 0.18 ± 0.53 (0.08, 0.27) | 2.99 | 0.0836 |
| Baseline‐WK4 | 0.30 ± 0.57 (0.19, 0.40) | 0.37 ± 0.68 (0.25, 0.50) | 1.03 | 0.3107 |
| Baseline‐MTH3 | 0.25 ± 0.66 (0.12, 0.38) | 0.61 ± 0.75 (0.46, 0.75) | 10.95 | 0.0009 |
| Baseline‐MTH6 | 0.38 ± 0.68 (0.24, 0.52) | 0.65 ± 0.76 (0.49, 0.80) | 6.65 | 0.0099 |
| ΔMAS‐Wrist flexors muscle | ||||
| Baseline‐WK2 | 0.06 ± 0.53 (−0.04, 0.16) | 0.15 ± 0.56 (0.05, 0.25) | 2.79 | 0.0951 |
| Baseline‐WK4 | 0.06 ± 0.65 (−0.06, 0.19) | 0.31 ± 0.74 (0.18, 0.44) | 8.19 | 0.0042 |
| Baseline‐MTH3 | 0.05 ± 0.81 (−0.11, 0.20) | 0.47 ± 0.82 (0.31, 0.62) | 13.60 | 0.0002 |
| Baseline‐MTH6 | 0.16 ± 0.89 (−0.03, 0.34) | 0.53 ± 0.75 (0.37, 0.68) | 11.63 | 0.0006 |
| ΔMAS‐Finger flexors muscle | ||||
| Baseline‐WK2 | 0.03 ± 0.35 (−0.03, 0.10) | 0.10 ± 0.56 (0.00, 0.20) | 3.06 | 0.0804 |
| Baseline‐WK4 | 0.10 ± 0.56 (−0.01, 0.20) | 0.24 ± 0.71 (0.11, 0.36) | 5.14 | 0.0234 |
| Baseline‐MTH3 | 0.07 ± 0.65 (−0.06, 0.19) | 0.39 ± 0.72 (0.25, 0.53) | 13.55 | 0.0002 |
| Baseline‐MTH6 | 0.03 ± 0.77 (−0.13, 0.19) | 0.43 ± 0.65 (0.29, 0.56) | 13.96 | 0.0002 |
| ΔFMA‐T | ||||
| Baseline‐WK2 | −3.19 ± 4.48 (−4.01, −2.37) | −5.65 ± 7.36 (−6.95, −4.34) | 9.59 | 0.0022 |
| Baseline‐WK4 | −7.39 ± 8.54 (−8.99, −5.78) | −11.73 ± 10.42 (−13.59, −9.87) | 12.01 | 0.0006 |
| Baseline‐MTH3 | −12.83 ± 12.78 (−15.30, −10.35) | −20.03 ± 13.89 (−22.69, −17.36) | 15.40 | 0.0001 |
| Baseline‐MTH6 | −17.61 ± 16.78 (−21.13, −14.10) | −25.10 ± 16.76 (−28.53, −21.66) | 9.16 | 0.0028 |
| ΔFMA‐U | ||||
| Baseline‐WK2 | −1.67 ± 2.89 (−2.20, −1.14) | −3.87 ± 5.41 (−4.83, −2.91) | 15.14 | 0.0001 |
| Baseline‐WK4 | −3.99 ± 5.38 (−5.00, −2.98) | −7.75 ± 7.58 (−9.10, −6.40) | 18.75 | <0.0001 |
| Baseline‐MTH3 | −7.65 ± 8.27 (−9.25, −6.05) | −13.48 ± 10.06 (−15.41, −11.55) | 21.19 | <0.0001 |
| Baseline‐MTH6 | −10.89 ± 11.40 (−13.28, −8.50) | −17.10 ± 12.33 (−19.62, −14.57) | 12.54 | 0.0005 |
| ΔMBI | ||||
| Baseline‐WK2 | −3.83 ± 6.63 (−5.05, −2.61) | −5.27 ± 6.75 (−6.47, −4.08) | 2.80 | 0.0954 |
| Baseline‐WK4 | −9.50 ± 10.10 (−11.40, −7.60) | −11.67 ± 10.75 (−13.59, −9.76) | 2.54 | 0.1124 |
| Baseline‐MTH3 | −14.60 ± 13.50 (−17.21, −11.99) | −16.99 ± 12.33 (−19.35, −14.63) | 1.81 | 0.1795 |
| Baseline‐MTH6 | −18.78 ± 17.77 (−22.50, −15.06) | −26.12 ± 20.21 (−30.28, −21.96) | 6.79 | 0.0099 |
The data are presented as the mean ± standard deviation (SD), 95%CI. ΔChange in value before versus after treatment.
MAS, Modified Ashworth Scale; FMA‐U, Fugl‐Meyer upper limb score; FMA‐T, Fugl‐Meyer total score; MBI, Modified Barthel Index; WK, week; MTH, month. CR, Conventional rehabilitation group TN, Tui Na group.